AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP 62_CD Form_NN 20-F_JJ Information_NN 2003_CD Group_NNP Profit_NN and_CC Loss_NN Account_NNP for_IN the_DT year_NN ended_VBD 31_CD December_NNP Before_IN exceptional_JJ Exceptional_JJ 2003_CD items_NNS items_NNS Total_JJ Notes_NNP $_$ m_CD $_$ m_CD $_$ m_CD Group_NNP turnover_NN 18,849_CD 18,849_CD Operating_NN costs_NNS 1_CD 14,938_CD 14,938_CD Other_JJ operating_NN income_NN 1_CD 200_CD 200_CD Group_NNP operating_NN profit_NN 1_CD 4,111_CD 4,111_CD Share_NN of_IN operating_VBG profits_NNS of_IN joint_JJ ventures_NNS and_CC associates_NNS 2_CD Profits_NNS on_IN sale_NN of_IN fixed_JJ assets_NNS 3_CD Dividend_NN income_NN 2_CD 2_CD Profit_NN on_IN ordinary_JJ activities_NNS before_IN interest_NN 4,113_CD 4,113_CD Net_JJ interest_NN 489_CD 89_CD Profit_NN on_IN ordinary_JJ activities_NNS before_IN taxation_NN 4,202_CD 4,202_CD Taxation_NNP 5_CD 1,143_CD 1,143_CD Profit_NN on_IN ordinary_JJ activities_NNS after_IN taxation_NN 3,059_CD 3,059_CD Attributable_JJ to_TO minorities_NNS 23_CD 23_CD Net_JJ profit_NN for_IN the_DT financial_JJ year_NN 3,036_CD 3,036_CD Dividends_NNS to_TO shareholders_NNS 6_CD 1,350_CD Profit_NN retained_VBN for_IN the_DT financial_JJ year_NN 1,686_CD Earnings_NNS per_IN $_$ 0.25_CD Ordinary_NNP Share_NN before_IN exceptional_JJ items_NNS 7_CD $_$ 1.78_CD $_$ 1.78_CD Earnings_NNS per_IN $_$ 0.25_CD Ordinary_NNP Share_NNP basic_JJ 7_CD $_$ 1.78_CD $_$ 1.78_CD Earnings_NNS per_IN $_$ 0.25_CD Ordinary_NNP Share_NNP diluted_VBD 7_CD $_$ 1.78_CD $_$ 1.78_CD Weighted_VBN average_JJ number_NN of_IN Ordinary_NNP Shares_NNP in_IN issue_NN millions_NNS 7_CD 1,709_CD All_DT activities_NNS were_VBD in_IN respect_NN of_IN continuing_VBG operations_NNS ._.
There_EX were_VBD no_DT material_NN differences_NNS between_IN reported_VBN profits_NNS and_CC losses_NNS and_CC historical_JJ cost_NN profits_NNS and_CC losses_NNS on_IN ordinary_JJ activities_NNS before_IN taxation_NN ._.
Group_NNP Statement_NNP of_IN Total_NNP Recognised_NNP Gains_NNS and_CC Losses_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2003_CD Notes_NNP $_$ m_CD Net_JJ profit_NN for_IN the_DT financial_JJ year_NN 3,036_CD Foreign_NNP exchange_NN adjustments_NNS on_IN consolidation_NN 20_CD 1,361_CD Tax_NNP on_IN foreign_JJ exchange_NN adjustments_NNS on_IN consolidation_NN 20_CD 66_CD Translation_NN differences_NNS on_IN foreign_JJ currency_NN borrowings_NNS 20_CD Tax_NNP on_IN translation_NN differences_NNS on_IN foreign_JJ currency_NN borrowings_NNS 20_CD Total_JJ recognized_VBN gains_NNS and_CC losses_NNS relating_VBG to_TO the_DT financial_JJ year_NN 4,463_CD $_$ m_JJ means_NNS millions_NNS of_IN US_NNP dollars_NNS
